{"id":26114,"date":"2023-04-28T15:04:07","date_gmt":"2023-04-28T19:04:07","guid":{"rendered":"https:\/\/genomequebec.wp.vortexdev.com\/?p=26114"},"modified":"2024-01-12T17:26:59","modified_gmt":"2024-01-12T22:26:59","slug":"funding-for-innovative-therapies-for-hereditary-ataxias","status":"publish","type":"post","link":"https:\/\/genomequebec.wp.vortexdev.com\/en\/news-and-publications\/funding-for-innovative-therapies-for-hereditary-ataxias\/","title":{"rendered":"Funding for innovative therapies for hereditary ataxias"},"content":{"rendered":"\n

It is with great enthusiasm that G\u00e9nome Qu\u00e9bec, Ataxia Canada and Muscular Dystrophy Canada announce the launch of the Innovative Therapies for Hereditary Ataxias<\/strong><\/a> competition to encourage the discovery and development of new therapies and to mobilize the research ecosystem. The three organizations aim to jointly invest $1M to support three projects with a maximum of $330,000 per project for a period of two years. <\/p>\n\n\n\n

The goal of this competition is to meet the needs of people affected by these rare neurological diseases, to enable them to benefit from genomic innovations and to encourage the development of innovative therapies. It supports the objectives and orientations of the provincial and federal governments, notably by accelerating therapeutic innovation (Politique qu\u00e9b\u00e9coise pour les maladies rares<\/a>) and by supporting research to improve access to affordable and effective drugs for the treatment of rare diseases<\/a>. <\/p>\n\n\n\n

Read the Press release<\/a><\/strong><\/p>\n\n\n\n